| |
| |
|
| Insider
Information: |
Zoth Lota S |
| Relationship: |
Director |
| City: |
Gaithersburg |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
54,903 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$37,048 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
54,903 |
|
|
| Total
Value |
$37,048 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Medimmune Inc |
MEDI |
Senior Vice President ... |
2007-02-13 |
0 |
|
0 |
Premium* |
|
|
Lumos Pharma Inc |
LUMO |
Director |
2021-05-20 |
2,187 |
2014-01-02 |
0 |
Premium* |
|
|
Hyperion Therapeutics Inc |
HPTX |
Director |
2015-05-07 |
0 |
2014-05-27 |
0 |
Premium* |
|
|
Spark Therapeutics, Inc. |
ONCE |
CHIEF SCIENTIFIC OFFIC... |
2019-12-17 |
0 |
2018-05-31 |
0 |
Premium* |
|
|
Inovio Biomedical Corp |
INO |
Director |
2023-06-05 |
52,716 |
2020-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INO |
Inovio Biomedical Corp |
Director |
– • – |
2023-06-05 |
4 |
AS |
$0.56 |
$3,192 |
D/D |
(5,700) |
52,716 |
0 |
% |
|
| INO |
Inovio Biomedical Corp |
Director |
– • – |
2023-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,000 |
58,416 |
0 |
- |
|
| INO |
Inovio Biomedical Corp |
Director |
– • – |
2022-05-16 |
4 |
AS |
$1.98 |
$7,128 |
D/D |
(3,600) |
39,416 |
0 |
% |
|
| INO |
Inovio Biomedical Corp |
Director |
– • – |
2022-05-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,000 |
43,016 |
0 |
- |
|
| INO |
Inovio Biomedical Corp |
Director |
– • – |
2022-01-05 |
4 |
AS |
$5.01 |
$4,815 |
D/D |
(961) |
25,016 |
0 |
% |
|
| INO |
Inovio Biomedical Corp |
Director |
– • – |
2022-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,090 |
25,977 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
367 |
2,187 |
0 |
- |
|
| INO |
Inovio Biomedical Corp |
Director |
– • – |
2021-05-17 |
4 |
AS |
$6.62 |
$13,538 |
D/D |
(2,045) |
21,887 |
0 |
% |
|
| INO |
Inovio Biomedical Corp |
Director |
– • – |
2021-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,700 |
23,932 |
0 |
- |
|
| INO |
Inovio Biomedical Corp |
Director |
– • – |
2021-01-05 |
4 |
AS |
$9.48 |
$9,110 |
D/D |
(961) |
15,232 |
0 |
% |
|
| INO |
Inovio Biomedical Corp |
Director |
– • – |
2021-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,090 |
16,193 |
0 |
- |
|
| INO |
Inovio Biomedical Corp |
Director |
– • – |
2020-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,013 |
12,103 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2020-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
709 |
1,820 |
0 |
- |
|
| INO |
Inovio Biomedical Corp |
Director |
– • – |
2020-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,090 |
4,090 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2020-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,100 |
10,006 |
0 |
- |
|
| ONCE |
Spark Therapeutics, Inc. |
CHIEF SCIENTIFIC OFFICER |
• • – |
2019-12-17 |
4 |
D |
$114.50 |
$343,500 |
D/D |
(3,000) |
0 |
0 |
- |
|
| ONCE |
Spark Therapeutics, Inc. |
Director |
– • – |
2019-05-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,500 |
3,000 |
0 |
- |
|
| ONCE |
Spark Therapeutics, Inc. |
Director |
– • – |
2018-05-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,500 |
1,500 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
Director |
– • – |
2015-05-07 |
4 |
D |
$46.00 |
$120,382 |
D/D |
(2,617) |
0 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2015-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,962 |
7,906 |
0 |
- |
|
| HPTX |
Hyperion Therapeutics Inc |
Director |
– • – |
2014-05-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,617 |
2,617 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2014-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,944 |
5,944 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Director |
– • – |
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| MEDI |
Medimmune Inc |
Senior Vice President & CFO |
• – – |
2007-02-13 |
4 |
S |
$31.10 |
$46,206 |
D/D |
(1,463) |
0 |
0 |
- |
|
| MEDI |
Medimmune Inc |
Chief Financial OfficerOfficer |
• – – |
2004-01-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
178 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
